Digital Therapeutics Alliance: The Future of Medicine - Optimizing the Patient Experience With PDURS
October 29, 2024
October 29, 2024
ARLINGTON, Virginia, Oct. 29 -- The Digital Therapeutics Alliance issued the following statement on Oct. 28, 2024:
The FDA's recent Prescription Drug Use-Related Software (PDURS) guidance has the potential to transform both the patient and provider experience by integrating digital tools directly with prescription therapies. This advancement allows software to enhance medication use through support for side effect management, adherence, and overall patient engagement, represent . . .
The FDA's recent Prescription Drug Use-Related Software (PDURS) guidance has the potential to transform both the patient and provider experience by integrating digital tools directly with prescription therapies. This advancement allows software to enhance medication use through support for side effect management, adherence, and overall patient engagement, represent . . .